➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Boehringer Ingelheim
Mallinckrodt
Moodys
Harvard Business School

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

ERYTHROMYCIN LACTOBIONATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Erythromycin Lactobionate, and what generic alternatives are available?

Erythromycin Lactobionate is a drug marketed by Abraxis Pharm, Baxter Hlthcare, and Teva Parenteral. and is included in three NDAs.

The generic ingredient in ERYTHROMYCIN LACTOBIONATE is erythromycin lactobionate. There are one hundred and three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin lactobionate profile page.

Summary for ERYTHROMYCIN LACTOBIONATE
Drug patent expirations by year for ERYTHROMYCIN LACTOBIONATE
Recent Clinical Trials for ERYTHROMYCIN LACTOBIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Prof Dr Jan TackN/A
Universitaire Ziekenhuizen LeuvenN/A
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3

See all ERYTHROMYCIN LACTOBIONATE clinical trials

US Patents and Regulatory Information for ERYTHROMYCIN LACTOBIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062604-002 Nov 24, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062993-001 May 9, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Abraxis Pharm ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062604-001 Nov 24, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062993-002 May 9, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Colorcon
AstraZeneca
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.